When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Eye drops recalled over fungal concerns: Here's which Systane ...

   www.aol.com/eye-drops-recalled-over-fungal...

   Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count: Lot 10101, which expires in September 2025. The eye drops are used to temporarily relieve "burning and irritation in persons ...

3. Systane eye drops recalled for possible fungal contamination ...

   www.aol.com/news/systane-eye-drops-recalled...

   One lot of Systane Lubricant Eye Drops Ultra PF was recalled following a consumer complaint “of foreign material observed inside a sealed single-use vial,” the FDA said in a release. It was ...

4. FDA Announces Nationwide Eye Drops Recall Due to Fungal ...

   www.aol.com/lifestyle/fda-announces-nationwide...

   Alcon, the company behind the Systane eye drops brand, said it was recalling a single lot of its Systane Lubricant Eye Drops Ultra PF, in an announcement released by the Food and Drug Administration.

5. Artificial tears - Wikipedia

   en.wikipedia.org/wiki/Artificial_tears

   Patients who use artificial tears more frequently than four to six times a day should choose a brand without preservatives or one with non-irritating preservatives. [10] Thicker artificial tears that come in the form of gel or ointments may be used in more severe cases as they last longer, although they may temporarily blur vision. [ 1 ]

6. Safety data sheet - Wikipedia

   en.wikipedia.org/wiki/Safety_data_sheet

   An example SDS, including guidance for handling a hazardous substance and information on its composition and properties. A safety data sheet (SDS), [1] material safety data sheet (MSDS), or product safety data sheet (PSDS) is a document that lists information relating to occupational safety and health for the use of various substances and products.

7. Visine - Wikipedia

   en.wikipedia.org/wiki/Visine

   Visine (/ ˌ v aɪ ˈ z iː n /), also known as Vispring, is a brand of eye drops produced by Kenvue. [1] Visine was first introduced in 1958 and was acquired by Pfizer in 1999. [2] [3] In 2006, Johnson & Johnson acquired Visine, along with Pfizer's entire consumer healthcare portfolio. [4]